Exchange & Returns Information
Review Details
(4)
| Drug Type | Original |
|---|---|
| Active Ingredient | SONIDEGIB |
| Strength | 200MG |
| Manufacturer | NOVARTIS |
| Pack Size | Price Per Unit | Unit Price | QTY | CART | Best Coupon Price MAX DISCOUNT |
|---|---|---|---|---|---|
| 1 BOX - 30 CAPSULES | $ 239.73 | $ 7,192.00 |
$ 6,113.20
Apply ZARVY26 (-15%)
You save $ 1,078.80
|
||
| 2 BOXES - 60 CAPSULES | $ 236.53 |
1% $ 14,384.00
$ 14,192.00
|
$ 12,063.20
Apply ZARVY26 (-15%)
You save $ 2,128.80
|
||
| ★ Best Value 3 BOXES - 90 CAPSULES | $ 233.24 |
3% $ 21,576.00
$ 20,992.00
|
$ 17,843.20
Apply ZARVY26 (-15%)
You save $ 3,148.80
|
Reference information will be available soon.
Odomzo 200mg is an oral anticancer agent containing sonidegib, a potent Hedgehog pathway inhibitor indicated for the treatment of advanced basal cell carcinoma (BCC). It is primarily used in adult patients with locally advanced BCC that has recurred after surgery or radiation, or for those who are unsuitable for these treatments. By targeting a critical regulatory protein (Smoothened receptor) in the Hedgehog signaling cascade, Odomzo disrupts tumor growth mechanisms and suppresses the proliferation of malignant cells in the skin. This therapy offers a non-surgical, targeted alternative for patients with difficult-to-treat BCC.
- AntiCancer Drugs > Locally Advanced Basal Cell Carcinoma (BCC) Odomzo is used in adult patients with locally advanced BCC that has either recurred after prior surgical or radiation intervention or is deemed inoperable or unsuitable for radiation therapy. It provides a non-invasive, molecularly targeted option for controlling progressive or aggressive BCC lesions where traditional treatments are not viable.
Sonidegib functions by inhibiting the Hedgehog (Hh) signaling pathway, specifically binding to and inactivating the Smoothened (SMO) receptor, a key transducer in the pathway. Since abnormal activation of this signaling is central to the development and progression of BCC, blocking it results in reduced tumor cell viability and a slowing of disease progression. The drug is associated with durable response rates and helps delay further tissue damage or spread in high-risk BCC cases.
Usual Adult Dose for Basal Cell Carcinoma: - 200 mg orally once daily - Continue therapy until disease progression or occurrence of unacceptable toxicity Comments: - Baseline serum creatinine kinase (CK) and renal function should be assessed prior to starting therapy. - Pregnancy testing must be performed in women of childbearing potential prior to initiation. - Capsules must be swallowed whole and should not be chewed, opened, or crushed. - May be taken with or without food.
Store at room temperature between 20–25°C (68–77°F). Protect from moisture and light. Keep the bottle tightly closed and out of reach of children. Do not refrigerate.
Common side effects include muscle spasms, fatigue, nausea, diarrhea, weight loss, and alopecia. More serious risks involve elevated creatine kinase levels, which may indicate muscle toxicity. Regular monitoring is essential to avoid rhabdomyolysis or renal impairment. Reproductive toxicity is a major concern—Odomzo is contraindicated in pregnancy and effective contraception must be used during and after treatment.
My dermatologist prescribed Odomzo, and this pharmacy is my reliable source for it. Their service is always professional and fast.
Reordering my Odomzo is never a hassle. The site is clean, simple, and very user-friendly, which I appreciate.
我的皮肤癌治疗需要持续服用奥多佐（Odomzo）。这家网站能稳定供货，而且服务专业，让我非常安心。
For a critical medication like this, you need a source you can depend on. They've been flawless with every order.
No combo deals available at the moment.
